News & Updates
Filter by Specialty:
Ambulatory better than central BP at predicting death, cardiovascular events in dialysis patients
Central blood pressure (BP) is associated with all-cause mortality and cardiovascular events in haemodialysis patients, reveals a study. However, its prognostic value is not superior to ambulatory peripheral BP.
Ambulatory better than central BP at predicting death, cardiovascular events in dialysis patients
18 Dec 2021IBD therapies do not increase risk of contracting COVID-19 after immunization
Using biologic/small molecules*, systemic steroids, or other agents** to treat patients with inflammatory bowel disease (IBD) does not increase the rate of SARS-CoV-2 infection at 3 and 6 months post-immunization, according to a study presented at AIBD 2021.
IBD therapies do not increase risk of contracting COVID-19 after immunization
18 Dec 2021Early vedolizumab treatment uncommon in IBD
In patients with inflammatory bowel disease (IBD), the likelihood of early treatment with vedolizumab is low, a finding that diverts from guideline recommendations, according to a real-world study presented at AIBD 2021.
Early vedolizumab treatment uncommon in IBD
17 Dec 2021Wrist strap monitors physiological changes in IBD
A novel health tracker that is strapped around the wrist can detect changes in the physiology of individuals with inflammatory bowel disease (IBD) in real time, as shown in a study presented at the Advances in Inflammatory Bowel Diseases conference.
Wrist strap monitors physiological changes in IBD
17 Dec 2021Remote management during chemotherapy fails to reduce ED visits, hospitalization
A remote, proactive, and telephone-based management of toxicities in outpatients during adjuvant or neoadjuvant chemotherapy for early-stage breast cancer does not lead to fewer visits to the emergency department (ED) or hospital admissions, a study has shown.